24 March 2021
Aquis Stock Exchange/ShareSoc research finds individual investors feel there are barriers to their ability to buy growth stocks
A survey undertaken by Aquis Stock Exchange (AQSE) and ShareSoc has shown that individual investors do not feel they have good, equal access to growth stocks.
Key findings of the survey1
· 55% of individual investors polled feel they don't have, or aren't sure they have, good access to growth companies
· Around 50% of respondents commented that they do not believe that they have enough access to IPOs and fundraises
· Individual investors are frustrated about the privileged access afforded to institutional investors, often at discounted prices
· Over 80% of respondents feel individual investors should be able to trade shares in any public company they choose, irrespective of the exchange it is on
Opportunities for the individual investor on AQSE
The survey showed that most individual investors are not taking up the trading opportunities available on AQSE. AQSE is a home to growth companies and is dedicated to providing better access to SME stocks for individual investors.
On the Apex segment of AQSE growth market:
- Individual investors are able to immediately participate in IPOs as a growth prospectus is required
- Short selling is prohibited (aside from Market Makers)
- Spreads are all within 5% - the result of its previously announced innovative Market Maker scheme.
AQSE is regulated by the FCA. Companies listed on AQSE are supported by established corporate advisers, with Canaccord, Liberum, Peel Hunt, Shore Capital, Stifel and Winterflood Securities all publicly supporting AQSE's Market Maker scheme.
AQSE is home to established high-profile names such as Shepherd Neame, Chapel Down, and Arbuthnot Banking, as well as companies at all stages of their growth journey including Samarkand Group and KR1. The average market cap of an Apex stock is approximately
Brokers that currently offer direct electronic trading in AQSE include Barclays Smart Invest, Jarvis and The Share Centre. Talks are taking place to extend coverage with AJ Bell, Hargreaves Lansdown, Interactive Investor and IG Capital.
ShareSoc support for equal access
ShareSoc believes that regulatory and access issues for individual investors also have consequences for the issuing companies and for the
• Liquidity, spreads, costs and ratings on
• Lack of individual investor access to IPOs and fundraises starves companies of essential growth capital at reasonable cost
These problems could be significantly ameliorated by making it easier and simpler for individual investors to access IPOs and fundraises and to trade shares in all public companies and on all exchanges.
Alasdair Haynes, CEO of Aquis Exchange, said:
"At AQSE, we aim to provide greater and better access to individual investors. Unfortunately, many investors are yet to benefit from AQSE's offering and our provisions for individual investors, including the access to companies from the IPO stage on the Apex segment of our growth market.
By providing more information about the benefits of AQSE I hope that more individual investors will choose to make the most of what it has to offer as we see more brokers giving them equal access through direct electronic trading."
Mike Dennis, Director of ShareSoc, added:
"Many
1The survey was completed by over 450 of ShareSoc's 7,000 members, in January 2021. Half of the respondents have a significant proportion (>20%) of their portfolios in small caps and two thirds of those with significant small cap portfolios define themselves as experienced investors
For more information please contact:
Aquis Stock Exchange
Belinda Keheyan, Head of Marketing +44 (0)7768 078 110
Alma PR +44 (0)20 3405 0209
Susie Hudson / Kieran Breheny / Faye Calow aquis@almapr.co.uk
ShareSoc
Mike Dennis mike.dennis@sharesoc.org
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.